FDA Amends Delegations of Authority for Prescription Drug User Fees

Summary

The FDA is updating its authority delegation for prescription drug user fees, transferring responsibility to the Center for Drug Evaluation and Research and the Associate Director for Policy, effective July 1, 1999, with some exceptions.